Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

Sorted by: relevance · author · university · dateNew search

You searched for subject:(TNF inhibitors). Showing records 1 – 19 of 19 total matches.

Search Limiters

Last 2 Years | English Only

No search limiters apply to these results.

▼ Search Limiters


University of Illinois – Chicago

1. Lee, Wan-Ju. Utilization and Risk of Serious Infection Associated with TNFInhibitors in Children and Young Adults.

Degree: 2016, University of Illinois – Chicago

 This dissertation examined use of tumor necrosis factor-alpha inhibitors (TNFI) and risk of TNFI-associated serious infection compared to oral immunosuppressants in children and young adults… (more)

Subjects/Keywords: TNF inhibitors; infections

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Lee, W. (2016). Utilization and Risk of Serious Infection Associated with TNF-α Inhibitors in Children and Young Adults. (Thesis). University of Illinois – Chicago. Retrieved from http://hdl.handle.net/10027/21614

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Lee, Wan-Ju. “Utilization and Risk of Serious Infection Associated with TNF-α Inhibitors in Children and Young Adults.” 2016. Thesis, University of Illinois – Chicago. Accessed March 04, 2021. http://hdl.handle.net/10027/21614.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Lee, Wan-Ju. “Utilization and Risk of Serious Infection Associated with TNF-α Inhibitors in Children and Young Adults.” 2016. Web. 04 Mar 2021.

Vancouver:

Lee W. Utilization and Risk of Serious Infection Associated with TNF-α Inhibitors in Children and Young Adults. [Internet] [Thesis]. University of Illinois – Chicago; 2016. [cited 2021 Mar 04]. Available from: http://hdl.handle.net/10027/21614.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Lee W. Utilization and Risk of Serious Infection Associated with TNF-α Inhibitors in Children and Young Adults. [Thesis]. University of Illinois – Chicago; 2016. Available from: http://hdl.handle.net/10027/21614

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

2. l' Ami, M.J. Towards personalized treatment of rheumatic diseases with TNF inhibitors.

Degree: 2020, NARCIS

Subjects/Keywords: Rheumatology; TNF inhibitors; personalised treatment

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

l' Ami, M. J. (2020). Towards personalized treatment of rheumatic diseases with TNF inhibitors. (Doctoral Dissertation). NARCIS. Retrieved from https://research.vumc.nl/en/publications/50c8df77-ef83-453e-bb9e-0871ec6a05bb ; urn:nbn:nl:ui:31-50c8df77-ef83-453e-bb9e-0871ec6a05bb ; 50c8df77-ef83-453e-bb9e-0871ec6a05bb ; urn:nbn:nl:ui:31-50c8df77-ef83-453e-bb9e-0871ec6a05bb ; https://research.vumc.nl/en/publications/50c8df77-ef83-453e-bb9e-0871ec6a05bb

Chicago Manual of Style (16th Edition):

l' Ami, M J. “Towards personalized treatment of rheumatic diseases with TNF inhibitors.” 2020. Doctoral Dissertation, NARCIS. Accessed March 04, 2021. https://research.vumc.nl/en/publications/50c8df77-ef83-453e-bb9e-0871ec6a05bb ; urn:nbn:nl:ui:31-50c8df77-ef83-453e-bb9e-0871ec6a05bb ; 50c8df77-ef83-453e-bb9e-0871ec6a05bb ; urn:nbn:nl:ui:31-50c8df77-ef83-453e-bb9e-0871ec6a05bb ; https://research.vumc.nl/en/publications/50c8df77-ef83-453e-bb9e-0871ec6a05bb.

MLA Handbook (7th Edition):

l' Ami, M J. “Towards personalized treatment of rheumatic diseases with TNF inhibitors.” 2020. Web. 04 Mar 2021.

Vancouver:

l' Ami MJ. Towards personalized treatment of rheumatic diseases with TNF inhibitors. [Internet] [Doctoral dissertation]. NARCIS; 2020. [cited 2021 Mar 04]. Available from: https://research.vumc.nl/en/publications/50c8df77-ef83-453e-bb9e-0871ec6a05bb ; urn:nbn:nl:ui:31-50c8df77-ef83-453e-bb9e-0871ec6a05bb ; 50c8df77-ef83-453e-bb9e-0871ec6a05bb ; urn:nbn:nl:ui:31-50c8df77-ef83-453e-bb9e-0871ec6a05bb ; https://research.vumc.nl/en/publications/50c8df77-ef83-453e-bb9e-0871ec6a05bb.

Council of Science Editors:

l' Ami MJ. Towards personalized treatment of rheumatic diseases with TNF inhibitors. [Doctoral Dissertation]. NARCIS; 2020. Available from: https://research.vumc.nl/en/publications/50c8df77-ef83-453e-bb9e-0871ec6a05bb ; urn:nbn:nl:ui:31-50c8df77-ef83-453e-bb9e-0871ec6a05bb ; 50c8df77-ef83-453e-bb9e-0871ec6a05bb ; urn:nbn:nl:ui:31-50c8df77-ef83-453e-bb9e-0871ec6a05bb ; https://research.vumc.nl/en/publications/50c8df77-ef83-453e-bb9e-0871ec6a05bb

3. l' Ami, M.J. Towards personalized treatment of rheumatic diseases with TNF inhibitors.

Degree: 2020, NARCIS

Subjects/Keywords: Rheumatology; TNF inhibitors; personalised treatment

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

l' Ami, M. J. (2020). Towards personalized treatment of rheumatic diseases with TNF inhibitors. (Doctoral Dissertation). NARCIS. Retrieved from https://research.vu.nl/en/publications/fbc3ba3a-b30b-49a7-9ec8-507defee57a9 ; urn:nbn:nl:ui:31-fbc3ba3a-b30b-49a7-9ec8-507defee57a9 ; fbc3ba3a-b30b-49a7-9ec8-507defee57a9 ; 1871.1/fbc3ba3a-b30b-49a7-9ec8-507defee57a9 ; urn:isbn:9789463757027 ; urn:nbn:nl:ui:31-fbc3ba3a-b30b-49a7-9ec8-507defee57a9 ; https://research.vu.nl/en/publications/fbc3ba3a-b30b-49a7-9ec8-507defee57a9

Chicago Manual of Style (16th Edition):

l' Ami, M J. “Towards personalized treatment of rheumatic diseases with TNF inhibitors.” 2020. Doctoral Dissertation, NARCIS. Accessed March 04, 2021. https://research.vu.nl/en/publications/fbc3ba3a-b30b-49a7-9ec8-507defee57a9 ; urn:nbn:nl:ui:31-fbc3ba3a-b30b-49a7-9ec8-507defee57a9 ; fbc3ba3a-b30b-49a7-9ec8-507defee57a9 ; 1871.1/fbc3ba3a-b30b-49a7-9ec8-507defee57a9 ; urn:isbn:9789463757027 ; urn:nbn:nl:ui:31-fbc3ba3a-b30b-49a7-9ec8-507defee57a9 ; https://research.vu.nl/en/publications/fbc3ba3a-b30b-49a7-9ec8-507defee57a9.

MLA Handbook (7th Edition):

l' Ami, M J. “Towards personalized treatment of rheumatic diseases with TNF inhibitors.” 2020. Web. 04 Mar 2021.

Vancouver:

l' Ami MJ. Towards personalized treatment of rheumatic diseases with TNF inhibitors. [Internet] [Doctoral dissertation]. NARCIS; 2020. [cited 2021 Mar 04]. Available from: https://research.vu.nl/en/publications/fbc3ba3a-b30b-49a7-9ec8-507defee57a9 ; urn:nbn:nl:ui:31-fbc3ba3a-b30b-49a7-9ec8-507defee57a9 ; fbc3ba3a-b30b-49a7-9ec8-507defee57a9 ; 1871.1/fbc3ba3a-b30b-49a7-9ec8-507defee57a9 ; urn:isbn:9789463757027 ; urn:nbn:nl:ui:31-fbc3ba3a-b30b-49a7-9ec8-507defee57a9 ; https://research.vu.nl/en/publications/fbc3ba3a-b30b-49a7-9ec8-507defee57a9.

Council of Science Editors:

l' Ami MJ. Towards personalized treatment of rheumatic diseases with TNF inhibitors. [Doctoral Dissertation]. NARCIS; 2020. Available from: https://research.vu.nl/en/publications/fbc3ba3a-b30b-49a7-9ec8-507defee57a9 ; urn:nbn:nl:ui:31-fbc3ba3a-b30b-49a7-9ec8-507defee57a9 ; fbc3ba3a-b30b-49a7-9ec8-507defee57a9 ; 1871.1/fbc3ba3a-b30b-49a7-9ec8-507defee57a9 ; urn:isbn:9789463757027 ; urn:nbn:nl:ui:31-fbc3ba3a-b30b-49a7-9ec8-507defee57a9 ; https://research.vu.nl/en/publications/fbc3ba3a-b30b-49a7-9ec8-507defee57a9


University of Ottawa

4. MacDonald, Erika. Exploration of Post-market Evidence of Effectiveness and Safety of TNF-alpha Inhibitors in Crohn’s and Colitis .

Degree: 2015, University of Ottawa

 The objectives of this thesis were to synthesize existing RCT evidence and post-market observational evidence of TNFinhibitors in IBD. Two separate systematic reviews were… (more)

Subjects/Keywords: TNF-alpha inhibitors; Crohn's disease; ulcerative colitis; inflammatory bowel disease; systematic review; overview; observational studies; Anti-TNF

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

MacDonald, E. (2015). Exploration of Post-market Evidence of Effectiveness and Safety of TNF-alpha Inhibitors in Crohn’s and Colitis . (Thesis). University of Ottawa. Retrieved from http://hdl.handle.net/10393/33416

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

MacDonald, Erika. “Exploration of Post-market Evidence of Effectiveness and Safety of TNF-alpha Inhibitors in Crohn’s and Colitis .” 2015. Thesis, University of Ottawa. Accessed March 04, 2021. http://hdl.handle.net/10393/33416.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

MacDonald, Erika. “Exploration of Post-market Evidence of Effectiveness and Safety of TNF-alpha Inhibitors in Crohn’s and Colitis .” 2015. Web. 04 Mar 2021.

Vancouver:

MacDonald E. Exploration of Post-market Evidence of Effectiveness and Safety of TNF-alpha Inhibitors in Crohn’s and Colitis . [Internet] [Thesis]. University of Ottawa; 2015. [cited 2021 Mar 04]. Available from: http://hdl.handle.net/10393/33416.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

MacDonald E. Exploration of Post-market Evidence of Effectiveness and Safety of TNF-alpha Inhibitors in Crohn’s and Colitis . [Thesis]. University of Ottawa; 2015. Available from: http://hdl.handle.net/10393/33416

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Universidade Federal da Bahia

5. Tania Maria Souto Luna Pinto. Effect of TNFinhibitors on peripheral blood mononuclear cells of HTLV-1- infected individuals.

Degree: 2005, Universidade Federal da Bahia

 O retovírus HTLV-I é o agente etiológico da Mielopatia Associada ao HTLV-I/ Paraparesia Espástica Tropical (HAM/TSP), Leucemia de Células T do Adulto (ATL) e outras… (more)

Subjects/Keywords: TNF-α; IMUNOLOGIA; human T-cell lymphotropic virus (HTLV-1); IFN-γ; TNF-α; IFN-γ; inhibitors; inibidores de TNF-α; vírus 1 linfotrópico T humano

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Pinto, T. M. S. L. (2005). Effect of TNF-α inhibitors on peripheral blood mononuclear cells of HTLV-1- infected individuals. (Thesis). Universidade Federal da Bahia. Retrieved from http://www.bibliotecadigital.ufba.br/tde_busca/arquivo.php?codArquivo=463 ; http://www.bibliotecadigital.ufba.br/tde_busca/arquivo.php?codArquivo=464 ; http://www.bibliotecadigital.ufba.br/tde_busca/arquivo.php?codArquivo=465

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Pinto, Tania Maria Souto Luna. “Effect of TNF-α inhibitors on peripheral blood mononuclear cells of HTLV-1- infected individuals.” 2005. Thesis, Universidade Federal da Bahia. Accessed March 04, 2021. http://www.bibliotecadigital.ufba.br/tde_busca/arquivo.php?codArquivo=463 ; http://www.bibliotecadigital.ufba.br/tde_busca/arquivo.php?codArquivo=464 ; http://www.bibliotecadigital.ufba.br/tde_busca/arquivo.php?codArquivo=465.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Pinto, Tania Maria Souto Luna. “Effect of TNF-α inhibitors on peripheral blood mononuclear cells of HTLV-1- infected individuals.” 2005. Web. 04 Mar 2021.

Vancouver:

Pinto TMSL. Effect of TNF-α inhibitors on peripheral blood mononuclear cells of HTLV-1- infected individuals. [Internet] [Thesis]. Universidade Federal da Bahia; 2005. [cited 2021 Mar 04]. Available from: http://www.bibliotecadigital.ufba.br/tde_busca/arquivo.php?codArquivo=463 ; http://www.bibliotecadigital.ufba.br/tde_busca/arquivo.php?codArquivo=464 ; http://www.bibliotecadigital.ufba.br/tde_busca/arquivo.php?codArquivo=465.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Pinto TMSL. Effect of TNF-α inhibitors on peripheral blood mononuclear cells of HTLV-1- infected individuals. [Thesis]. Universidade Federal da Bahia; 2005. Available from: http://www.bibliotecadigital.ufba.br/tde_busca/arquivo.php?codArquivo=463 ; http://www.bibliotecadigital.ufba.br/tde_busca/arquivo.php?codArquivo=464 ; http://www.bibliotecadigital.ufba.br/tde_busca/arquivo.php?codArquivo=465

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Vrije Universiteit Amsterdam

6. Krieckaert, C.L.M. Pharmacokinetics and immunogenicity of TNF-inhibitors, towards optimised treatment of rheumatoid arthritis .

Degree: 2013, Vrije Universiteit Amsterdam

Subjects/Keywords: pharmacokinetics; immunogenicity; rheumatoid arthritis; TNF-inhibitors

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Krieckaert, C. L. M. (2013). Pharmacokinetics and immunogenicity of TNF-inhibitors, towards optimised treatment of rheumatoid arthritis . (Doctoral Dissertation). Vrije Universiteit Amsterdam. Retrieved from http://hdl.handle.net/1871/47901

Chicago Manual of Style (16th Edition):

Krieckaert, C L M. “Pharmacokinetics and immunogenicity of TNF-inhibitors, towards optimised treatment of rheumatoid arthritis .” 2013. Doctoral Dissertation, Vrije Universiteit Amsterdam. Accessed March 04, 2021. http://hdl.handle.net/1871/47901.

MLA Handbook (7th Edition):

Krieckaert, C L M. “Pharmacokinetics and immunogenicity of TNF-inhibitors, towards optimised treatment of rheumatoid arthritis .” 2013. Web. 04 Mar 2021.

Vancouver:

Krieckaert CLM. Pharmacokinetics and immunogenicity of TNF-inhibitors, towards optimised treatment of rheumatoid arthritis . [Internet] [Doctoral dissertation]. Vrije Universiteit Amsterdam; 2013. [cited 2021 Mar 04]. Available from: http://hdl.handle.net/1871/47901.

Council of Science Editors:

Krieckaert CLM. Pharmacokinetics and immunogenicity of TNF-inhibitors, towards optimised treatment of rheumatoid arthritis . [Doctoral Dissertation]. Vrije Universiteit Amsterdam; 2013. Available from: http://hdl.handle.net/1871/47901


University of Toronto

7. Ling, Juejing. Pregnancy Outcomes After Exposures to TNF-Alpha Inhibitors in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis with the Application of GRADE Assessment.

Degree: 2017, University of Toronto

This systematic review examined on whether there are more adverse pregnancy outcomes among inflammatory bowel disease (IBD) patients taking TNF-alpha inhibitors (TNFi) in pregnancy compared… (more)

Subjects/Keywords: GRADE; Inflammatory Bowel Disease; Meta-Analysis; Pregnancy; Systematic Review; TNF-alpha Inhibitors; 0572

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Ling, J. (2017). Pregnancy Outcomes After Exposures to TNF-Alpha Inhibitors in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis with the Application of GRADE Assessment. (Masters Thesis). University of Toronto. Retrieved from http://hdl.handle.net/1807/79391

Chicago Manual of Style (16th Edition):

Ling, Juejing. “Pregnancy Outcomes After Exposures to TNF-Alpha Inhibitors in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis with the Application of GRADE Assessment.” 2017. Masters Thesis, University of Toronto. Accessed March 04, 2021. http://hdl.handle.net/1807/79391.

MLA Handbook (7th Edition):

Ling, Juejing. “Pregnancy Outcomes After Exposures to TNF-Alpha Inhibitors in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis with the Application of GRADE Assessment.” 2017. Web. 04 Mar 2021.

Vancouver:

Ling J. Pregnancy Outcomes After Exposures to TNF-Alpha Inhibitors in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis with the Application of GRADE Assessment. [Internet] [Masters thesis]. University of Toronto; 2017. [cited 2021 Mar 04]. Available from: http://hdl.handle.net/1807/79391.

Council of Science Editors:

Ling J. Pregnancy Outcomes After Exposures to TNF-Alpha Inhibitors in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis with the Application of GRADE Assessment. [Masters Thesis]. University of Toronto; 2017. Available from: http://hdl.handle.net/1807/79391

8. Immediato-Daien, Claire. Analyse des lymphocytes B dans la polyarthrite rhumatoïde : phénotypage, étude des B régulateurs et des lymphocytes B comme biomarqueurs de réponse aux biomédicaments. : Study of B cells in rheumatoid arthritis : phenotyping, regulatory B cell analysis and B cells as predictive biomarker of response to biodrugs.

Degree: Docteur es, Biologie Cellulaire, 2014, Université Montpellier I

 Le lymphocyte B (LB) joue un rôle important dans la polyarthrite rhumatoïde (PR), en produisant des auto-anticorps qui ont un rôle pathogène, en activant les… (more)

Subjects/Keywords: Polyarthrite rhumatoïde; Lymphocytes B; B régulateurs; Anti-TNF; Inhibiteur du récepteur de l'IL-6; Rheumatoid arthritis; B cells; Regulatory B cells; TNF inhibitors; Anti-IL-6 receptor

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Immediato-Daien, C. (2014). Analyse des lymphocytes B dans la polyarthrite rhumatoïde : phénotypage, étude des B régulateurs et des lymphocytes B comme biomarqueurs de réponse aux biomédicaments. : Study of B cells in rheumatoid arthritis : phenotyping, regulatory B cell analysis and B cells as predictive biomarker of response to biodrugs. (Doctoral Dissertation). Université Montpellier I. Retrieved from http://www.theses.fr/2014MON1T001

Chicago Manual of Style (16th Edition):

Immediato-Daien, Claire. “Analyse des lymphocytes B dans la polyarthrite rhumatoïde : phénotypage, étude des B régulateurs et des lymphocytes B comme biomarqueurs de réponse aux biomédicaments. : Study of B cells in rheumatoid arthritis : phenotyping, regulatory B cell analysis and B cells as predictive biomarker of response to biodrugs.” 2014. Doctoral Dissertation, Université Montpellier I. Accessed March 04, 2021. http://www.theses.fr/2014MON1T001.

MLA Handbook (7th Edition):

Immediato-Daien, Claire. “Analyse des lymphocytes B dans la polyarthrite rhumatoïde : phénotypage, étude des B régulateurs et des lymphocytes B comme biomarqueurs de réponse aux biomédicaments. : Study of B cells in rheumatoid arthritis : phenotyping, regulatory B cell analysis and B cells as predictive biomarker of response to biodrugs.” 2014. Web. 04 Mar 2021.

Vancouver:

Immediato-Daien C. Analyse des lymphocytes B dans la polyarthrite rhumatoïde : phénotypage, étude des B régulateurs et des lymphocytes B comme biomarqueurs de réponse aux biomédicaments. : Study of B cells in rheumatoid arthritis : phenotyping, regulatory B cell analysis and B cells as predictive biomarker of response to biodrugs. [Internet] [Doctoral dissertation]. Université Montpellier I; 2014. [cited 2021 Mar 04]. Available from: http://www.theses.fr/2014MON1T001.

Council of Science Editors:

Immediato-Daien C. Analyse des lymphocytes B dans la polyarthrite rhumatoïde : phénotypage, étude des B régulateurs et des lymphocytes B comme biomarqueurs de réponse aux biomédicaments. : Study of B cells in rheumatoid arthritis : phenotyping, regulatory B cell analysis and B cells as predictive biomarker of response to biodrugs. [Doctoral Dissertation]. Université Montpellier I; 2014. Available from: http://www.theses.fr/2014MON1T001


University of Helsinki

9. Nenonen, Satu. Tuumorinekroositekijän salpaajien kustannusvaikuttavuus selkärankareuman hoidossa.

Degree: Farmaceutiska fakulteten, 2017, University of Helsinki

 Selkärankareuma on tulehduksellinen reumasairaus, joka ilmenee tyypillisesti nuorella aikuisiällä. Selkärankareuman oireisiin kuuluu levossa pahentuva tulehduksellinen selkäkipu, lanne- ja rintarangan jäykkyys sekä perifeeriset tulehdukset. Pohjoiseurooppalaisen väestön… (more)

Subjects/Keywords: ankylosing spondylitis; TNF inhibitors; infliximab; etanercept; adalimumab; golimumab; cost-effectiveness; patient-level simulation model; selkärankareuma; TNF-salpaajat; infliksimabi; etanersepti; adalimumabi; golimumabi; kustannusvaikuttavuus; potilaskohtainen simulaatio; Socialfarmaci; Social Pharmacy; Sosiaalifarmasia

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Nenonen, S. (2017). Tuumorinekroositekijän salpaajien kustannusvaikuttavuus selkärankareuman hoidossa. (Masters Thesis). University of Helsinki. Retrieved from http://hdl.handle.net/10138/228522

Chicago Manual of Style (16th Edition):

Nenonen, Satu. “Tuumorinekroositekijän salpaajien kustannusvaikuttavuus selkärankareuman hoidossa.” 2017. Masters Thesis, University of Helsinki. Accessed March 04, 2021. http://hdl.handle.net/10138/228522.

MLA Handbook (7th Edition):

Nenonen, Satu. “Tuumorinekroositekijän salpaajien kustannusvaikuttavuus selkärankareuman hoidossa.” 2017. Web. 04 Mar 2021.

Vancouver:

Nenonen S. Tuumorinekroositekijän salpaajien kustannusvaikuttavuus selkärankareuman hoidossa. [Internet] [Masters thesis]. University of Helsinki; 2017. [cited 2021 Mar 04]. Available from: http://hdl.handle.net/10138/228522.

Council of Science Editors:

Nenonen S. Tuumorinekroositekijän salpaajien kustannusvaikuttavuus selkärankareuman hoidossa. [Masters Thesis]. University of Helsinki; 2017. Available from: http://hdl.handle.net/10138/228522


Universidade Nova

10. Neves, Marisa Alexandra Fernandes das. Homogneous time resolved fluorescence: a new technique for detection and quantifications of infliximab in autoimmune patients .

Degree: 2012, Universidade Nova

 RESUMO:As terapias biológicas revolucionaram o tratamento das doenças autoimunes nos últimos anos. Tipicamente têm como alvos mediadores importantes no mecanismo das doenças. Os antagonistas do… (more)

Subjects/Keywords: Tumor Necrosis Factor-alpha - antagonists & inhibitors; Spectrometry, Fluorescence; Immunogenicity; Pharmacokinetics; Inibidores do TNF-alpha; Imunogenicidade; Farmacocinética; Fluorescência; Farmacologia

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Neves, M. A. F. d. (2012). Homogneous time resolved fluorescence: a new technique for detection and quantifications of infliximab in autoimmune patients . (Thesis). Universidade Nova. Retrieved from http://www.rcaap.pt/detail.jsp?id=oai:run.unl.pt:10362/9083

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Neves, Marisa Alexandra Fernandes das. “Homogneous time resolved fluorescence: a new technique for detection and quantifications of infliximab in autoimmune patients .” 2012. Thesis, Universidade Nova. Accessed March 04, 2021. http://www.rcaap.pt/detail.jsp?id=oai:run.unl.pt:10362/9083.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Neves, Marisa Alexandra Fernandes das. “Homogneous time resolved fluorescence: a new technique for detection and quantifications of infliximab in autoimmune patients .” 2012. Web. 04 Mar 2021.

Vancouver:

Neves MAFd. Homogneous time resolved fluorescence: a new technique for detection and quantifications of infliximab in autoimmune patients . [Internet] [Thesis]. Universidade Nova; 2012. [cited 2021 Mar 04]. Available from: http://www.rcaap.pt/detail.jsp?id=oai:run.unl.pt:10362/9083.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Neves MAFd. Homogneous time resolved fluorescence: a new technique for detection and quantifications of infliximab in autoimmune patients . [Thesis]. Universidade Nova; 2012. Available from: http://www.rcaap.pt/detail.jsp?id=oai:run.unl.pt:10362/9083

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Ottawa

11. Adam, Nadine Jessica. Tweak and cIAP1 Mediate Alternative NF-κB Signalling to Promote Myogenesis .

Degree: 2016, University of Ottawa

 The NF-κB family of transcription factors can be activated through canonical (classical) or non-canonical (alternative) signalling pathways, which are regulated by the redundant ubiquitin ligases,… (more)

Subjects/Keywords: myogenesis; NF-κB signalling; cellular inhibitors of apoptosis (cIAPs); TNF-like weak inducer of apoptosis (TWEAK); myoblast fusion; myoblast differentiation; smac-mimetic compounds

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Adam, N. J. (2016). Tweak and cIAP1 Mediate Alternative NF-κB Signalling to Promote Myogenesis . (Thesis). University of Ottawa. Retrieved from http://hdl.handle.net/10393/34223

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Adam, Nadine Jessica. “Tweak and cIAP1 Mediate Alternative NF-κB Signalling to Promote Myogenesis .” 2016. Thesis, University of Ottawa. Accessed March 04, 2021. http://hdl.handle.net/10393/34223.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Adam, Nadine Jessica. “Tweak and cIAP1 Mediate Alternative NF-κB Signalling to Promote Myogenesis .” 2016. Web. 04 Mar 2021.

Vancouver:

Adam NJ. Tweak and cIAP1 Mediate Alternative NF-κB Signalling to Promote Myogenesis . [Internet] [Thesis]. University of Ottawa; 2016. [cited 2021 Mar 04]. Available from: http://hdl.handle.net/10393/34223.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Adam NJ. Tweak and cIAP1 Mediate Alternative NF-κB Signalling to Promote Myogenesis . [Thesis]. University of Ottawa; 2016. Available from: http://hdl.handle.net/10393/34223

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

12. Mettou, Anthoula. Ανακάλυψη αναστολέων για την πρωτεΐνη TNF-α σαν ενώσεις οδηγούς για φάρμακα έναντι της ρευματοειδoύς αρθρίτιδας.

Degree: 2017, University of Thessaly (UTH); Πανεπιστήμιο Θεσσαλίας

 The subject of this thesis is the discovery of novel small-molecule inhibitors of Tumor Necrosis Factor (TNF). TNF has been related to autoimmune diseases such… (more)

Subjects/Keywords: Αναστολείς TNF-α; SPD304; Βιοενεργότητα; Διαλυτότητα μικρών φαρμακοφόρων μορίων; Ενίσχυση υδατικής διαλυτότητας; Κρυσταλλογραφία πρωτεϊνών με ακτίνες-Χ; Inhibitors of TNF-α; SPD304; Bioactivity; Solubility of small drug molecules; Aqueous solubility enhancement; X-Ray Protein crystallography

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Mettou, A. (2017). Ανακάλυψη αναστολέων για την πρωτεΐνη TNF-α σαν ενώσεις οδηγούς για φάρμακα έναντι της ρευματοειδoύς αρθρίτιδας. (Thesis). University of Thessaly (UTH); Πανεπιστήμιο Θεσσαλίας. Retrieved from http://hdl.handle.net/10442/hedi/41794

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Mettou, Anthoula. “Ανακάλυψη αναστολέων για την πρωτεΐνη TNF-α σαν ενώσεις οδηγούς για φάρμακα έναντι της ρευματοειδoύς αρθρίτιδας.” 2017. Thesis, University of Thessaly (UTH); Πανεπιστήμιο Θεσσαλίας. Accessed March 04, 2021. http://hdl.handle.net/10442/hedi/41794.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Mettou, Anthoula. “Ανακάλυψη αναστολέων για την πρωτεΐνη TNF-α σαν ενώσεις οδηγούς για φάρμακα έναντι της ρευματοειδoύς αρθρίτιδας.” 2017. Web. 04 Mar 2021.

Vancouver:

Mettou A. Ανακάλυψη αναστολέων για την πρωτεΐνη TNF-α σαν ενώσεις οδηγούς για φάρμακα έναντι της ρευματοειδoύς αρθρίτιδας. [Internet] [Thesis]. University of Thessaly (UTH); Πανεπιστήμιο Θεσσαλίας; 2017. [cited 2021 Mar 04]. Available from: http://hdl.handle.net/10442/hedi/41794.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Mettou A. Ανακάλυψη αναστολέων για την πρωτεΐνη TNF-α σαν ενώσεις οδηγούς για φάρμακα έναντι της ρευματοειδoύς αρθρίτιδας. [Thesis]. University of Thessaly (UTH); Πανεπιστήμιο Θεσσαλίας; 2017. Available from: http://hdl.handle.net/10442/hedi/41794

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

13. Papadopoulos, Christos. Οι βιολογικοί παράγοντες ως θεραπεία των χρόνιων φλεγμονωδών αρθροπαθειών.

Degree: 2017, University of Ioannina; Πανεπιστήμιο Ιωαννίνων

 Biological therapies broadened new therapeutic horizons in the treatment of the chronic inflammatory arthropathies. It has been shown that these drugs are effective both for… (more)

Subjects/Keywords: Βιολογικοί παράγοντες; TNF-α αναστολείς; Ινφλιξιμάμπη; Ετανερσέπτη; Ανταλιμουμάμπη; Χρόνιες φλεγμονώδεις αρθροπάθειες; Ρευματοειδής αρθρίτιδα; Ψωριασική αρθρίτιδα; Αγκυλοποιητική σπονδυλίτιδα; Ανεπιθύμητες ενέργειες; Επιβίωση φαρμάκων; Biologic agents; TNF-α inhibitors; Infliximab; Etanercept; Adalimumab; Chronic inflammatory arthropathies; Reumatoid arthritis; Psoriatic arthritis; Ankylosing spondylitis; Adverse events; Drug survival

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Papadopoulos, C. (2017). Οι βιολογικοί παράγοντες ως θεραπεία των χρόνιων φλεγμονωδών αρθροπαθειών. (Thesis). University of Ioannina; Πανεπιστήμιο Ιωαννίνων. Retrieved from http://hdl.handle.net/10442/hedi/45017

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Papadopoulos, Christos. “Οι βιολογικοί παράγοντες ως θεραπεία των χρόνιων φλεγμονωδών αρθροπαθειών.” 2017. Thesis, University of Ioannina; Πανεπιστήμιο Ιωαννίνων. Accessed March 04, 2021. http://hdl.handle.net/10442/hedi/45017.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Papadopoulos, Christos. “Οι βιολογικοί παράγοντες ως θεραπεία των χρόνιων φλεγμονωδών αρθροπαθειών.” 2017. Web. 04 Mar 2021.

Vancouver:

Papadopoulos C. Οι βιολογικοί παράγοντες ως θεραπεία των χρόνιων φλεγμονωδών αρθροπαθειών. [Internet] [Thesis]. University of Ioannina; Πανεπιστήμιο Ιωαννίνων; 2017. [cited 2021 Mar 04]. Available from: http://hdl.handle.net/10442/hedi/45017.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Papadopoulos C. Οι βιολογικοί παράγοντες ως θεραπεία των χρόνιων φλεγμονωδών αρθροπαθειών. [Thesis]. University of Ioannina; Πανεπιστήμιο Ιωαννίνων; 2017. Available from: http://hdl.handle.net/10442/hedi/45017

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

14. Oladapo, Abiola Oluwagbenga. Medication adherence, persistence, switching and dose escalation with the use of tumor necrosis factor (TNF) inhibitors among Texas Medicaid patients diagnosed with rheumatoid arthritis.

Degree: PhD, Pharmacy, 2013, University of Texas – Austin

 The main purpose of this study was to evaluate medication use patterns (i.e., dose escalation, medication adherence, persistence, and switching) of rheumatoid arthritis (RA) patients… (more)

Subjects/Keywords: Rheumatoid arthritis; Medication adherence; Persistence; Switching; Dose escalation; Tumor necrosis factor (TNF) inhibitors

…48 2.1.11 Medication Switching among TNF Inhibitors in RA Management… …Dose Escalation among TNF Inhibitors .............................................137 Table… …among TNF Inhibitors.............................................................144 Table… …Therapy among TNF Inhibitors Users… …Linear Regression Analysis Comparing Total Healthcare Utilization Cost among TNF Inhibitors… 

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Oladapo, A. O. (2013). Medication adherence, persistence, switching and dose escalation with the use of tumor necrosis factor (TNF) inhibitors among Texas Medicaid patients diagnosed with rheumatoid arthritis. (Doctoral Dissertation). University of Texas – Austin. Retrieved from http://hdl.handle.net/2152/21383

Chicago Manual of Style (16th Edition):

Oladapo, Abiola Oluwagbenga. “Medication adherence, persistence, switching and dose escalation with the use of tumor necrosis factor (TNF) inhibitors among Texas Medicaid patients diagnosed with rheumatoid arthritis.” 2013. Doctoral Dissertation, University of Texas – Austin. Accessed March 04, 2021. http://hdl.handle.net/2152/21383.

MLA Handbook (7th Edition):

Oladapo, Abiola Oluwagbenga. “Medication adherence, persistence, switching and dose escalation with the use of tumor necrosis factor (TNF) inhibitors among Texas Medicaid patients diagnosed with rheumatoid arthritis.” 2013. Web. 04 Mar 2021.

Vancouver:

Oladapo AO. Medication adherence, persistence, switching and dose escalation with the use of tumor necrosis factor (TNF) inhibitors among Texas Medicaid patients diagnosed with rheumatoid arthritis. [Internet] [Doctoral dissertation]. University of Texas – Austin; 2013. [cited 2021 Mar 04]. Available from: http://hdl.handle.net/2152/21383.

Council of Science Editors:

Oladapo AO. Medication adherence, persistence, switching and dose escalation with the use of tumor necrosis factor (TNF) inhibitors among Texas Medicaid patients diagnosed with rheumatoid arthritis. [Doctoral Dissertation]. University of Texas – Austin; 2013. Available from: http://hdl.handle.net/2152/21383


Kent State University

15. Ghimirey, Nirmala. Combination of Th1 cytokines plus small molecule kinase inhibitors Palbociclib or Sunitinib potentiate apoptosis in breast cancer cell lines.

Degree: MS, College of Arts and Sciences / School of Biomedical Sciences, 2018, Kent State University

 Vaccine-induced, Th1-polarized immunity can have a positive impact on early HER-2pos breast cancer, especially when combined with drugs that block estrogen signaling. This suggests that… (more)

Subjects/Keywords: Biomedical Research; Vaccination, Interferon-gamma, TNF-alpha, Sunitinib, Palbociclib, Ibrance, HER-2 positive, breast cancer, Th1 cytokines, cytokines, Tumor necrosis factor, MDAMB468, MDAMB231, MCF7, HCC1419, SKBR3, JIMT1, CDK4-6 inhibitors, RTK inhibitor

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Ghimirey, N. (2018). Combination of Th1 cytokines plus small molecule kinase inhibitors Palbociclib or Sunitinib potentiate apoptosis in breast cancer cell lines. (Masters Thesis). Kent State University. Retrieved from http://rave.ohiolink.edu/etdc/view?acc_num=kent1530017347709489

Chicago Manual of Style (16th Edition):

Ghimirey, Nirmala. “Combination of Th1 cytokines plus small molecule kinase inhibitors Palbociclib or Sunitinib potentiate apoptosis in breast cancer cell lines.” 2018. Masters Thesis, Kent State University. Accessed March 04, 2021. http://rave.ohiolink.edu/etdc/view?acc_num=kent1530017347709489.

MLA Handbook (7th Edition):

Ghimirey, Nirmala. “Combination of Th1 cytokines plus small molecule kinase inhibitors Palbociclib or Sunitinib potentiate apoptosis in breast cancer cell lines.” 2018. Web. 04 Mar 2021.

Vancouver:

Ghimirey N. Combination of Th1 cytokines plus small molecule kinase inhibitors Palbociclib or Sunitinib potentiate apoptosis in breast cancer cell lines. [Internet] [Masters thesis]. Kent State University; 2018. [cited 2021 Mar 04]. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=kent1530017347709489.

Council of Science Editors:

Ghimirey N. Combination of Th1 cytokines plus small molecule kinase inhibitors Palbociclib or Sunitinib potentiate apoptosis in breast cancer cell lines. [Masters Thesis]. Kent State University; 2018. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=kent1530017347709489


University of Debrecen

16. Björnsson, Aron Hjalti. Modern therapeutics in rheumatoid arthritis and spondyloarthritis .

Degree: DE – Általános Orvostudományi Kar, University of Debrecen

 Two decades ago, the introduction of the TNF inhibitors revolutionised the treatment of rheumatoid arthritis and spondyloarthritis. In the years to follow, more targeted therapies… (more)

Subjects/Keywords: Rheumatology; Arthritis; RA; Spondyloarthritis; TNF inhibitors; TNF blockers; Biologics; Small molecule drugs; Psoriasis arthritis; Rheumatoid arthitis; Ustekinumab; Secukinumab; Brodalumab; Ixekizumab; Tofacitinib; Baricitinib; infliximab; etanercept; adalimumab; certolizumab pegol; certolizumab; golimumab

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Björnsson, A. H. (n.d.). Modern therapeutics in rheumatoid arthritis and spondyloarthritis . (Thesis). University of Debrecen. Retrieved from http://hdl.handle.net/2437/247217

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Björnsson, Aron Hjalti. “Modern therapeutics in rheumatoid arthritis and spondyloarthritis .” Thesis, University of Debrecen. Accessed March 04, 2021. http://hdl.handle.net/2437/247217.

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Björnsson, Aron Hjalti. “Modern therapeutics in rheumatoid arthritis and spondyloarthritis .” Web. 04 Mar 2021.

Note: this citation may be lacking information needed for this citation format:
No year of publication.

Vancouver:

Björnsson AH. Modern therapeutics in rheumatoid arthritis and spondyloarthritis . [Internet] [Thesis]. University of Debrecen; [cited 2021 Mar 04]. Available from: http://hdl.handle.net/2437/247217.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.

Council of Science Editors:

Björnsson AH. Modern therapeutics in rheumatoid arthritis and spondyloarthritis . [Thesis]. University of Debrecen; Available from: http://hdl.handle.net/2437/247217

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.

17. Gerlach-Runge, Undine Ariane. Umgang mit immunologischen Herausforderungen nach Dünndarmtransplantation.

Degree: 2017, Freie Universität Berlin

 Trotz steigender Fallzahlen ist die Dünndarmtransplantation (Intestinal Transplantation - ITX) noch immer eine seltene Organtransplantation. Aufgrund der mit ihr verbundenen immunologischen und chirurgischen Herausforderungen wird… (more)

Subjects/Keywords: intestinal transplantation; abdominal wall; rejection markers; histocompatibility; TNF-a inhibitors; Non-HLA antibodies; 600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit

…in Intestinal Transplantation TNF-alpha Inhibitors as Immunomodulators to Reduce Early and… …further use of TNF-alpha inhibitors to reduce early and late inflammatory graft injury. 2.1… …TNF-alpha Inhibitors Like Infliximab Attenuate Ischaemia/Reperfusion Injury Gerlach UA… …study, we investigated the effects of different TNF-alpha inhibitors (infliximab… …effects of TNF-alpha inhibitors like infliximab on the different forms of immune activation was… 

Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Gerlach-Runge, U. A. (2017). Umgang mit immunologischen Herausforderungen nach Dünndarmtransplantation. (Thesis). Freie Universität Berlin. Retrieved from https://refubium.fu-berlin.de/handle/fub188/13684

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Gerlach-Runge, Undine Ariane. “Umgang mit immunologischen Herausforderungen nach Dünndarmtransplantation.” 2017. Thesis, Freie Universität Berlin. Accessed March 04, 2021. https://refubium.fu-berlin.de/handle/fub188/13684.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Gerlach-Runge, Undine Ariane. “Umgang mit immunologischen Herausforderungen nach Dünndarmtransplantation.” 2017. Web. 04 Mar 2021.

Vancouver:

Gerlach-Runge UA. Umgang mit immunologischen Herausforderungen nach Dünndarmtransplantation. [Internet] [Thesis]. Freie Universität Berlin; 2017. [cited 2021 Mar 04]. Available from: https://refubium.fu-berlin.de/handle/fub188/13684.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Gerlach-Runge UA. Umgang mit immunologischen Herausforderungen nach Dünndarmtransplantation. [Thesis]. Freie Universität Berlin; 2017. Available from: https://refubium.fu-berlin.de/handle/fub188/13684

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Erasmus University Rotterdam

18. Kuijper, Martijn. Patient Outcomes in the Treatment of Rheumatoid Arthritis : Informing tapering decisions: Patiëntgebonden factoren bij de behandeling van reumatoïde artritis : relatie met opbouw en afbouw van medicatie.

Degree: 2018, Erasmus University Rotterdam

 Despite the advances that have been made in the medical treatment of Rheumatoid arthritis (RA), challenges to further optimize care for patients remain. Two of… (more)

Subjects/Keywords: Rheumatoid Arthritis; disease activity score (DAS); psychosocial aspects; depression; anxiety; fatigue; coping; health related quality of life; tapering; remission; treatment de-escalation; disease modifying anti-rheumatic drugs (DMARDs); TNF-inhibitors; biologicals; discrete choice experiment (DCE); systematic review

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Kuijper, M. (2018). Patient Outcomes in the Treatment of Rheumatoid Arthritis : Informing tapering decisions: Patiëntgebonden factoren bij de behandeling van reumatoïde artritis : relatie met opbouw en afbouw van medicatie. (Doctoral Dissertation). Erasmus University Rotterdam. Retrieved from http://hdl.handle.net/1765/104843

Chicago Manual of Style (16th Edition):

Kuijper, Martijn. “Patient Outcomes in the Treatment of Rheumatoid Arthritis : Informing tapering decisions: Patiëntgebonden factoren bij de behandeling van reumatoïde artritis : relatie met opbouw en afbouw van medicatie.” 2018. Doctoral Dissertation, Erasmus University Rotterdam. Accessed March 04, 2021. http://hdl.handle.net/1765/104843.

MLA Handbook (7th Edition):

Kuijper, Martijn. “Patient Outcomes in the Treatment of Rheumatoid Arthritis : Informing tapering decisions: Patiëntgebonden factoren bij de behandeling van reumatoïde artritis : relatie met opbouw en afbouw van medicatie.” 2018. Web. 04 Mar 2021.

Vancouver:

Kuijper M. Patient Outcomes in the Treatment of Rheumatoid Arthritis : Informing tapering decisions: Patiëntgebonden factoren bij de behandeling van reumatoïde artritis : relatie met opbouw en afbouw van medicatie. [Internet] [Doctoral dissertation]. Erasmus University Rotterdam; 2018. [cited 2021 Mar 04]. Available from: http://hdl.handle.net/1765/104843.

Council of Science Editors:

Kuijper M. Patient Outcomes in the Treatment of Rheumatoid Arthritis : Informing tapering decisions: Patiëntgebonden factoren bij de behandeling van reumatoïde artritis : relatie met opbouw en afbouw van medicatie. [Doctoral Dissertation]. Erasmus University Rotterdam; 2018. Available from: http://hdl.handle.net/1765/104843

19. Londono-Joshi, Angelina Ix-Ik'. Investigation Of Death Receptor-5 Mediated Apoptosis And Inhibition Of Wnt/β-Catenin Signaling In Basal-Like Breast Cancer Stem Cells.

Degree: 2013, University of Alabama – Birmingham

Basal-like breast cancers (BLBC) display aggressive clinical behavior attributed to the presence of cancer stem cells (CSCs). TRA-8, a monoclonal antibody that binds specifically to… (more)

Subjects/Keywords: Antibodies, Monoclonal – toxicity.<; /br>; Antineoplastic Agents – toxicity<; /br>; Breast Neoplasms – metabolism<; /br>; Neoplasms, Basal Cell – metabolism.<; /br>; Neoplastic Stem Cells – drug effects.<; /br>; Receptors, TNF-Related Apoptosis-Inducing Ligand – antagonists & inhibitors.

…TOPflash TCF luciferase reporter constructs TRAIL TNF-Related Apoptosis-Inducing Ligand UAB… …35]. Five members of the TNF receptor superfamily have been shown to bind TRAIL; DR4… …carcinogenesis [54, 55]. Inhibition of Wnt Signaling A number of pharmacological inhibitors… 

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Londono-Joshi, A. I. (2013). Investigation Of Death Receptor-5 Mediated Apoptosis And Inhibition Of Wnt/β-Catenin Signaling In Basal-Like Breast Cancer Stem Cells. (Thesis). University of Alabama – Birmingham. Retrieved from http://contentdm.mhsl.uab.edu/u?/etd,1655

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Londono-Joshi, Angelina Ix-Ik'. “Investigation Of Death Receptor-5 Mediated Apoptosis And Inhibition Of Wnt/β-Catenin Signaling In Basal-Like Breast Cancer Stem Cells.” 2013. Thesis, University of Alabama – Birmingham. Accessed March 04, 2021. http://contentdm.mhsl.uab.edu/u?/etd,1655.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Londono-Joshi, Angelina Ix-Ik'. “Investigation Of Death Receptor-5 Mediated Apoptosis And Inhibition Of Wnt/β-Catenin Signaling In Basal-Like Breast Cancer Stem Cells.” 2013. Web. 04 Mar 2021.

Vancouver:

Londono-Joshi AI. Investigation Of Death Receptor-5 Mediated Apoptosis And Inhibition Of Wnt/β-Catenin Signaling In Basal-Like Breast Cancer Stem Cells. [Internet] [Thesis]. University of Alabama – Birmingham; 2013. [cited 2021 Mar 04]. Available from: http://contentdm.mhsl.uab.edu/u?/etd,1655.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Londono-Joshi AI. Investigation Of Death Receptor-5 Mediated Apoptosis And Inhibition Of Wnt/β-Catenin Signaling In Basal-Like Breast Cancer Stem Cells. [Thesis]. University of Alabama – Birmingham; 2013. Available from: http://contentdm.mhsl.uab.edu/u?/etd,1655

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

.